Hdl cholesterol low
Pro Research Analysisby 
Searched over 200M research papers
Prevalence and Demographics of Low HDL Cholesterol
Low high-density lipoprotein cholesterol (HDL-C) is relatively common in adults, with recent U.S. data showing a prevalence of 13.8% among adults aged 20 and older. The condition is more frequent in men (21.5%) than in women (6.6%), and its prevalence declines with age in both sexes. Over the past decade, the prevalence of low HDL-C has decreased in the U.S. population . Physical activity plays a significant role: adults who do not meet recommended physical activity guidelines have a higher prevalence of low HDL-C (21.0%) compared to those who are physically active (17.7%) .
Causes and Clinical Evaluation of Low HDL Cholesterol
Extremely low HDL-C levels (below 20 mg/dL) require careful evaluation. Secondary causes such as androgen use, certain cancers, and rare genetic disorders (like apolipoprotein A-I mutations, Tangier disease, and lecithin-cholesterol acyltransferase deficiency) should be considered. It is important to confirm low HDL-C in the absence of severe hypertriglyceridemia and to assess for other metabolic or inflammatory conditions Rader2012März2017. Lifestyle factors, including lack of exercise and smoking, are common contributors to low HDL-C März2017Zwald2017.
Cardiovascular Risk and HDL Cholesterol
Traditionally, HDL-C has been labeled as "good cholesterol" due to its inverse association with cardiovascular disease risk, especially in healthy individuals. However, recent research suggests that this relationship is more complex. While low HDL-C is associated with higher cardiovascular risk in the general population, this association may not hold in people with metabolic disorders or existing cardiovascular disease Rohatgi2021März2017Xiang2019. Furthermore, raising HDL-C levels with medication has not consistently reduced cardiovascular events, indicating that HDL-C concentration alone may not be a reliable therapeutic target Rohatgi2021März2017Xiang2019.
Despite these nuances, HDL-C remains a useful component in cardiovascular risk prediction models, particularly in primary prevention settings. Even among patients with very low LDL cholesterol levels (below 70 mg/dL), lower HDL-C is still linked to a higher risk of major cardiovascular events .
HDL Function Versus HDL Cholesterol Levels
HDL particles have multiple functions beyond cholesterol transport, including anti-inflammatory, antioxidant, and antidiabetic effects. The protective roles of HDL depend on the number, size, and composition of HDL particles, which are not fully captured by measuring HDL-C alone. In some cases, HDL can even have negative vascular effects if its composition is altered by disease Rohatgi2021März2017Xiang2019. Current research is shifting toward assessing HDL function rather than just HDL-C levels for a more accurate understanding of cardiovascular risk Rohatgi2021Xiang2019.
Low HDL Cholesterol and Other Health Risks
Low HDL-C is linked to increased risks beyond heart disease. Large population studies have shown that individuals with low HDL-C have a higher risk of developing autoimmune diseases and several types of cancer, including hematological, nervous system, breast, and respiratory cancers Madsen2019Pedersen2020. Additionally, both low and very high HDL-C levels are associated with a greater risk of infectious diseases, suggesting a U-shaped relationship between HDL-C and infection risk .
Management and Lifestyle Interventions
For most people, increasing HDL-C through lifestyle changes—such as regular physical activity and smoking cessation—can have positive health effects and is recommended. However, targeting HDL-C with medication is not currently supported by evidence for reducing cardiovascular events März2017Xiang2019Zwald2017. When low HDL-C is detected, it should prompt a broader evaluation for underlying metabolic or inflammatory conditions Rader2012März2017.
Conclusion
Low HDL cholesterol is common and associated with increased risks for cardiovascular disease, autoimmune disorders, certain cancers, and infections. While HDL-C remains a useful risk marker, its role as a therapeutic target is limited. The focus is shifting toward understanding and improving HDL function, and lifestyle changes remain the cornerstone of management for low HDL-C.
Sources and full results
Most relevant research papers on this topic